Publications by authors named "Fabio Monari"

Claim this Profile
L
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with RaCl: Ten Years of Clinical Experience.
Maria Silvia De Feo, Luca Filippi, Matteo Bauckneht, Elisa Lodi Rizzini, Cristina Ferrari, Fabio Monari

Diagnostics (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study.
Maria Silvia De Feo, Viviana Frantellizzi, Matteo Bauckneht, Alessio Farcomeni, Luca Filippi, Fabio Monari

Biomedicines· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected Widespread Bone Metastases from a BRAF K601N Mutated Follicular Thyroid Carcinoma within a Previously Resected Multinodular Goiter.
Andrea Repaci, Nicola Salituro, Valentina Vicennati, Fabio Monari, Ottavio Cavicchi

Endocr Pathol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma.
Margherita Nannini, Andrea Repaci, Gianluca Ricco, Manuela Ianni, Arber Golemi, Fabio Monari

Front Oncol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic radiotherapy (SRT) for differentiated thyroid cancer (DTC) oligometastases: an AIRO (Italian association of radiotherapy and clinical oncology) systematic review.
Valentina Lancellotta, Giuseppe Fanetti, Fabio Monari, Monica Mangoni, Renzo Mazzarotto

Radiol Med· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra Study.
Matteo Bauckneht, Sara Elena Rebuzzi, Marta Ponzano, Roberto Borea, Alessio Signori, Fabio Monari

Cancers (Basel)· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radium-223 in mCPRC patients: a large real-life Italian multicenter study.
Viviana Frantellizzi, Fabio Monari, Manlio Mascia, Renato P Costa, Giuseppe Rubini

Minerva Urol Nephrol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study).
Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, Viviana Frantellizzi, Veronica Murianni, Fabio Monari

Eur J Nucl Med Mol Imaging· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant radiotherapy and radioiodine treatment for locally advanced differentiated thyroid cancer: systematic review and meta-analysis.
Samantha Dicuonzo, Sara Pedretti, Monica Mangoni, Fabio Monari, Giuseppe Fanetti

Tumori· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study.
Matteo Serenari, Alberta Cappelli, Alessandro Cucchetti, Cristina Mosconi, Lidia Strigari, Fabio Monari

Liver Transpl· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of 18F-FDG PET/CT on Clinical Management of Suspected Radio-Iodine Refractory Differentiated Thyroid Cancer (RAI-R-DTC).
Elisa Lodi Rizzini, Andrea Repaci, Elena Tabacchi, Lucia Zanoni, Valentina Vicennati, Fabio Monari

Diagnostics (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Usefulness of PET/CT with F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study.
Luca Filippi, Viviana Frantellizzi, Fabio Monari, Elisa Lodi Rizzini, Elena Tabacchi

Diagnostics (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without Ra.
Orazio Caffo, Viviana Frantellizzi, Fabio Monari, Luca Galli, Renato Patrizio Costa

Cancer Biother Radiopharm· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.
Viviana Frantellizzi, Fabio Monari, Manlio Mascia, Renato Costa, Giuseppe Rubini

Aging Clin Exp Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.
Orazio Caffo, Viviana Frantellizzi, Fabio Monari, Andrea Sbrana, Renato Patrizio Costa

Future Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Giorgio Grani, Maria Chiara Zatelli, Marco Alfò, Teresa Montesano, Massimo Torlontano, Fabio Monari

Thyroid· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Advanced Gastro-Entero-Pancreatic Neuro-Endocrine Tumors: A Systematic Review and Network Meta-Analysis of Phase III Randomized Controlled Trials.
Claudio Ricci, Giuseppe Lamberti, Carlo Ingaldi, Cristina Mosconi, Nico Pagano, Fabio Monari

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall survival in mCPRC patients treated with Radium-223 in association with bone health agents: a national multicenter study.
Viviana Frantellizzi, Fabio Monari, Manlio Mascia, Renato Costa, Giuseppe Rubini

Int J Radiat Biol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
Orazio Caffo, Viviana Frantellizzi, Marcello Tucci, Luca Galli, Fabio Monari

Eur J Nucl Med Mol Imaging· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with Radium-dichloride: a national multicenter study.
Viviana Frantellizzi, Fabio Monari, Manlio Mascia, Renato Costa, Giuseppe Rubini

Ann Nucl Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical aspects of mCRPC management in patients treated with radium-223.
Elisa Lodi Rizzini, Valeria Dionisi, Pietro Ghedini, Alessio Giuseppe Morganti, Stefano Fanti, Fabio Monari

Sci Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk Stratification.
Giovanni Tallini, Antonio De Leo, Andrea Repaci, Dario de Biase, Maria Letizia Bacchi Reggiani, Fabio Monari

Cancers (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Importance of the correct assessment of bone fractures in the clinical management of metastatic castration-resistant prostate cancer treated with radium-223: A case report.
Elisa Lodi Rizzini, Pietro Ghedini, Raffaele Cardano, Chiara Bellarosa, Alessio Giuseppe Morganti, Fabio Monari

Mol Clin Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Radium-223 Dichloride in Patients With Osteonecrosis of the Jaw Induced by Zoledronic Acid: Report of 2 Cases.
Valeria Dionisi, Chiara Bellarosa, Raffaele Cardano, Elisa Lodi Rizzini, Pietro Ghedini, Fabio Monari

Clin Genitourin Cancer· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRAF V600E Status and Stimulated Thyroglobulin at Ablation Time Increase Prognostic Value of American Thyroid Association Classification Systems for Persistent Disease in Differentiated Thyroid Carcinoma.
Andrea Repaci, Valentina Vicennati, Alexandro Paccapelo, Ottavio Cavicchi, Nicola Salituro, Fabio Monari

Int J Endocrinol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis